Market Insight : Venous Thromboembolism Therapeutics Market Globally Grow at a CAGR of 6.40% by Revenue During the Forecast Period 2017-2021
ResearchMoz presents professional and in-depth study of "Global Venous Thromboembolism Therapeutics Market 2017-2021". The global VTE therapeutics market is expected to benefit from the growing incidence of VTE worldwide. According to the CDC, every year around 0.9 million individuals are affected by VTE in the US and 60,000 to 100,000 individuals in the US die of VTE. Further, the presence of high unmet medical needs is expected to fuel the market growth. For instance, according to the CDC approximately 50% of individuals with VTE will have long-term complications, and 33% of individuals will have a recurrence within ten years. Technavios analysts forecast the global venous thromboembolism therapeutic market to grow at a CAGR of 6.40% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global venous thromboembolism therapeutic market for 2017-2021. To calculate the market size, the report considers the ...